The FDA approved the use of Sucampo Pharmaceuticals' Rescula, or unoprostone isopropyl, for intraocular pressure reduction in patients with ocular hypertension or open-angle glaucoma. Sucampo plans to launch the drug in the first quarter.
Sucampo's glaucoma drug Rescula wins FDA clearance
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan